Education
About Us
Working with TipRanks
Follow Us
Anthony Colaluca Insider Profile
4 Followers
Anthony Colaluca, CFO at MedAssets, holds 540.08K shares in Claritev (Ticker: CTEV), holds 0.00 shares in MedAssets (Ticker: MDAS). Most recently, Anthony Colaluca Bought ― shares of Claritev on May 20, 2024 for an estimated value of 96.00K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-26.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Anthony Colaluca's holdings
Insider Roles
Director
Roles that Anthony Colaluca holds in companies
Most Profitable Insider Trade
The most profitable trade made by Anthony Colaluca
Anthony Colaluca's Trading History
MedAssets
Jan 27, 2016
―
Uninformative Sell
―
$0.00
Claritev
May 20, 2024
Director
Informative Buy
96.00K
$9.86M
List of latest transactions for each holding click on a transaction to see Anthony Colaluca's performance on stock
You May Also Like
Anthony Colaluca insider profile FAQ
What is the percentage of profitable transactions made by Anthony Colaluca?
The percentage of profitable transactions made by Anthony Colaluca is 0%.
What is the average return per transaction made by Anthony Colaluca?
The average return per transaction made by Anthony Colaluca is -26.10%.
What stocks does Anthony Colaluca hold?
Anthony Colaluca holds: MDAS, CTEV stocks.
What was Anthony Colaluca’s latest transaction?
Anthony Colaluca latest transaction was an Informative Buy of $96.00K.
What was Anthony Colaluca's most profitable transaction?
Anthony Colaluca’s most profitable transaction was an Informative Buy of CTEV stock on November 22, 2022. The return on the trade was -11.60%.
What is Anthony Colaluca's role in MedAssets?
Anthony Colaluca's role in MedAssets is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.